LINBREVIT
LIVE

Serial Number

79286200

Owner

NOVARTIS AG

Filing Date

Apr 24, 2020

Add to watchlist:

No watchlists yet
View on USPTO

LINBREVIT Trademark

Serial Number: 79286200 • Registration: 6172127

LINBREVIT is a trademark filed by NOVARTIS AG on April 24, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

SANDOZ AG (209 trademarks)

VIADUKTSTRASSE 3
BASEL 4051 , CH

Entity Type: 03

Gan & Lee Pharmaceuticals. (13 trademarks)

No. 8 Jingsheng North 3rd Street,

Entity Type: 98

Trademark Details

Filing Date

April 24, 2020

Registration Date

October 13, 2020

Published for Opposition

July 28, 2020

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

CHANGE OF OWNER RECEIVED FROM IB
Jan 3, 2025 CHLD
CHANGE OF OWNER RECEIVED FROM IB
Mar 26, 2021 CHLD
NOTIFICATION PROCESSED BY IB
Dec 25, 2020 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Dec 9, 2020 FICS
FINAL DISPOSITION PROCESSED
Dec 9, 2020 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Nov 12, 2020 GPAR
REGISTERED-PRINCIPAL REGISTER
Oct 13, 2020 R.PR
NOTIFICATION PROCESSED BY IB
Jul 31, 2020 GPNX
PUBLISHED FOR OPPOSITION
Jul 28, 2020 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 15, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 15, 2020 OP2R
NOTICE OF PUBLICATION
Jul 8, 2020 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 20, 2020 CNSA
ASSIGNED TO EXAMINER
Jun 19, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 9, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 3, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 2, 2020 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 28, 2020 REPR